COVID-19 second wave and clinical characteristics of cases in Uganda: A retrospective cross-sectional survey of confirmed SARS-CoV-2 cases, March–June 2021Original Paper Published on 2023-07-252024-09-05 Journal: Epidemiology and Infection [Category] update2024, [키워드] asymptomatic patients Characteristics COVID-19 second wave Uganda [DOI] 10.1017/S0950268823001164 PMC 바로가기 [Article Type] Original Paper
Trend in the proportion of subjects with SARS-CoV-2 infection without COVID-19 specific symptoms among patients admitted to a COVID-19 referral hospitalCOVID-19 전원 병원에 입원한 환자 중 COVID-19 특정 증상이 없는 SARS-CoV-2 감염 환자의 비율 추세Article Published on 2023-03-012023-07-11 Journal: European journal of internal medicine [Category] COVID19(2023년), [키워드] asymptomatic patients elderly Incidental COVID-19 Respiratory Support Vaccine [DOI] 10.1016/j.ejim.2022.12.001 PMC 바로가기
How and when does monkeypox (mpox) transmit: Implications for prevention and treatmentsArticle Published on 2023-01-052023-06-10 Journal: Front Pharmacol [Category] Fulltext, 원숭이두창, [키워드] asymptomatic patients mild-symptomatic patients Monkeypox virus seminal transmission Viral load [DOI] 10.3389/fphar.2022.1109928 PMC 바로가기
A Counterintuitive Neutrophil-Mediated Pattern in COVID-19 Patients Revealed through Transcriptomics AnalysisArticle Published on 2022-12-302023-07-11 Journal: Viruses [Category] COVID19(2023년), [키워드] asymptomatic patients COVID-19 epidemiology cytokine blunt gene signature machine learning natural language processing transcriptomics virus entry spike absence. [DOI] 10.3390/v15010104 PMC 바로가기
Statistical analysis supports UTR (untranslated region) deletion theory in SARS-CoV-2Article Published on 2022-12-012022-11-16 Journal: Virulence [Category] COVID19(2023년), SARS, 변종, [키워드] affected Analysis ancestor Asymptomatic asymptomatic patients clinical outcomes correlation Degradation deletion of the untranslated region demonstrated Deterioration driving early stage evaluate Evolution explain genetic influence Genome hospitalized patient indicated mathematical Mortality mortality rate Mutation nucleic acid nucleic acid degradation system Patient SARS-CoV-2 SARS-COV-2 infection significantly significantly more similarity strain Support Symptoms the epidemic Toxicity UTR viral genome viral toxicity viral toxicity. virulence virus virus genome was performed [DOI] 10.1080/21505594.2022.2132059 PMC 바로가기
SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic periodArticle Published on 2022-11-012022-11-16 Journal: Journal of Thrombosis and Thrombolysis [Category] SARS, 치료기술, [키워드] addition antibody Antigen Asymptomatic COVID-19 asymptomatic patients checked Computed tomography consecutive patient coronavirus coronavirus disease COVID-19 COVID-19 infection COVID-19 pandemic CTPA diagnosed Elderly patient had no Immunity increase in material pandemic participant Patient patients patients with comorbidity PE positive result pulmonary Pulmonary thromboembolism Research risk risk factor SARS-CoV-2 SARS-CoV-2 antibody serum sample significant increase the patient thrombosis tomography were measured [DOI] 10.1007/s11239-022-02703-8 PMC 바로가기
A comprehensive review of COVID-19 detection techniques: From laboratory systems to wearable devicesReview article Published on 2022-10-012022-10-05 Journal: Computers in biology and medicine [Category] COVID19(2023년), SARS, 바이오마커, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome Asymptomatic Asymptomatic COVID-19 asymptomatic individual asymptomatic patient asymptomatic patients blood pressure body temperature cardiovascular condition changes in coronavirus COVID-19 COVID-19 infection diagnostic Diseases domain effort Healthcare system identify immunoassays individual infected individual isothermal amplification Laboratory machine learning monitoring system novel coronavirus disease offer parameters Patient physiological resources respiratory infection reverse transcription robust RT-LAMP RT-PCR SARS-CoV-2 Screening shown spread of COVID-19 symptomatic and asymptomatic Symptomatic patients Transmission unique Vital Wearable systems [DOI] 10.1016/j.compbiomed.2022.106070 [Article Type] Review article
A systematic review and meta-analysis of the IgA seroprevalence in COVID-19 patients: Is there a role for IgA in COVID-19 diagnosis or severity?COVID-19 환자의 IgA 혈청 유병률에 대한 체계적인 검토 및 메타 분석: COVID-19 진단 또는 중증도에서 IgA의 역할이 있습니까?Meta-Analysis Published on 2022-10-012022-09-11 Journal: Microbiological research [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, 치료기술, [키워드] Abstract acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibody association asymptomatic patients Biomarker caused coronavirus coronavirus disease COVID-19 COVID-19 diagnosis COVID-19 disease determine diagnostic diagnostic test diagnostic tests disease Efficacy Health health problems Humoral response humoral responses IgA Immunity in some include Infection manuscript Meta-analysis Mild observé Patient problems produced Research respiratory SARS-CoV-2 SARS-CoV-2 PCR Seroprevalence severe acute respiratory syndrome Coronavirus Severe patient severe patients severity susceptibility symptomatic systematic review Vaccines [DOI] 10.1016/j.micres.2022.127105 PMC 바로가기 [Article Type] Meta-Analysis
A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)Article Published on 2022-09-272022-11-15 Journal: BMC Medicine [Category] SARS, 진단, [키워드] 95% confidence interval Administered age airway Analysis asymptomatic patients Bayesian camostat camostat mesilate cardiovascular diseases cells Chronic kidney disease chronic respiratory disease clinical conducted consecutive negative test conversion COVID-19 COVID-19 symptom Diabetes Mellitus dose double-blind Drug screening effective Efficacy and safety eight enrolled evaluate Factor first test hospital human airway epithelial hypertension indicated Japan median time Mild moderate multicenter no significant difference obesity parallel-group Patient patients patients with COVID-19 Placebo placebo-controlled study Positive test Prevent primary efficacy endpoint Randomized Randomized controlled trial receive reduce registry SARS-CoV-2 SARS-COV-2 infection the placebo group the primary endpoint Treatment two groups underlying disease viral clearance viral loads was performed were blinded were excluded without symptoms [DOI] 10.1186/s12916-022-02518-7 PMC 바로가기
Evaluation of water gargle samples for SARS-CoV-2 detection using Abbott ID NOW COVID-19 assayAbbott ID NOW COVID-19 분석을 사용한 SARS-CoV-2 검출을 위한 양치질 샘플 평가Article Published on 2022-09-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 치료기술, [키워드] 95% CI 95% confidence interval Abbott Abbott ID NOW acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 added addition amplification asymptomatic patient asymptomatic patients Chain Reaction compatible symptoms Coronavirus-2 COVID-19 cycle threshold evaluate gargle NAAT Nasal sample nasopharyngeal noninvasive nucleic acid nucleic acid amplification test Patient pipette polymerase chain reaction positive positive sample Randomly residual Reverse transcription-polymerase chain reaction RT-PCR SARS-CoV-2 SARS-CoV-2 detection SARS-COV-2 infection selected Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus shown significantly lower specimen Standard of care symptomatic patient Symptomatic patients water [DOI] 10.1002/jmv.27847 PMC 바로가기 [Article Type] Article